DK1824515T3 - Behandling af dermatitis med dehydroepiandrosteron-glukokortikoidkombinationer - Google Patents
Behandling af dermatitis med dehydroepiandrosteron-glukokortikoidkombinationerInfo
- Publication number
- DK1824515T3 DK1824515T3 DK05807524T DK05807524T DK1824515T3 DK 1824515 T3 DK1824515 T3 DK 1824515T3 DK 05807524 T DK05807524 T DK 05807524T DK 05807524 T DK05807524 T DK 05807524T DK 1824515 T3 DK1824515 T3 DK 1824515T3
- Authority
- DK
- Denmark
- Prior art keywords
- glucocorticoid
- dehydroepiandrosterone
- dermatitis
- combinations
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61271704P | 2004-09-24 | 2004-09-24 | |
US11/108,032 US8084444B2 (en) | 2004-09-24 | 2005-04-15 | Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations |
PCT/US2005/031850 WO2006036484A2 (fr) | 2004-09-24 | 2005-09-08 | Traitement de dermatite au moyen de combinaisons de deshydroepiandrosterone-glucocorticoide |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1824515T3 true DK1824515T3 (da) | 2009-06-29 |
Family
ID=36100080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05807524T DK1824515T3 (da) | 2004-09-24 | 2005-09-08 | Behandling af dermatitis med dehydroepiandrosteron-glukokortikoidkombinationer |
Country Status (9)
Country | Link |
---|---|
US (1) | US8084444B2 (fr) |
EP (1) | EP1824515B1 (fr) |
AT (1) | ATE427122T1 (fr) |
CA (1) | CA2581364A1 (fr) |
DE (1) | DE602005013690D1 (fr) |
DK (1) | DK1824515T3 (fr) |
ES (1) | ES2321857T3 (fr) |
PL (1) | PL1824515T3 (fr) |
WO (1) | WO2006036484A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2539952T3 (es) | 2008-06-30 | 2015-07-07 | Schwartz, Arthur | Formulaciones esteroideas tópicas |
US20100086581A1 (en) * | 2008-10-07 | 2010-04-08 | Ernest Bove | Method for purpura reduction and prevention |
WO2012129305A1 (fr) * | 2011-03-23 | 2012-09-27 | Pop Test Cortisol Llc | Polythérapie |
WO2017091681A1 (fr) | 2015-11-24 | 2017-06-01 | Aclaris Therapeutics, Inc. | Inhibiteurs de kinase sélectifs |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4496556A (en) * | 1982-08-16 | 1985-01-29 | Norman Orentreich | Topical applications for preventing dry skin |
WO1994008589A1 (fr) * | 1992-10-09 | 1994-04-28 | The Board Of Trustees Of The Leland Stanford Junior University | Traitement du lupus erythemateux systemique a la deshydroepiandrosterone |
WO1995015746A1 (fr) * | 1993-12-10 | 1995-06-15 | The School Of Pharmacy | Systemes d'administration de liposomes |
JPH07258091A (ja) * | 1994-03-17 | 1995-10-09 | Kyowa Hakko Kogyo Co Ltd | アトピー性皮膚炎治療剤 |
GB9612990D0 (en) * | 1996-06-20 | 1996-08-21 | Stanford Rock Ltd | Compositions and methods for the treatment of chronic infections |
US5861391A (en) * | 1997-01-29 | 1999-01-19 | Research Development Foundation | Use of dehydroepiandrosterone to treat primary adrenal insufficiency and Addison's disease |
US6479058B1 (en) * | 1999-09-02 | 2002-11-12 | Mccadden Michael E. | Composition for the topical treatment of poison ivy and other forms of contact dermatitis |
US6552010B1 (en) | 1999-11-12 | 2003-04-22 | Genelabs Technologies, Inc. | Treatment of SLE with dehydroepiandrosterone |
US6787532B2 (en) * | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
FR2848844B1 (fr) * | 2002-12-18 | 2005-05-06 | Oreal | Utilisation d'un alkylether d'hydroxystilbene pour le traitement des peaux seches |
-
2005
- 2005-04-15 US US11/108,032 patent/US8084444B2/en active Active
- 2005-09-08 WO PCT/US2005/031850 patent/WO2006036484A2/fr active Application Filing
- 2005-09-08 DE DE602005013690T patent/DE602005013690D1/de active Active
- 2005-09-08 ES ES05807524T patent/ES2321857T3/es active Active
- 2005-09-08 PL PL05807524T patent/PL1824515T3/pl unknown
- 2005-09-08 AT AT05807524T patent/ATE427122T1/de not_active IP Right Cessation
- 2005-09-08 EP EP05807524A patent/EP1824515B1/fr active Active
- 2005-09-08 CA CA002581364A patent/CA2581364A1/fr not_active Abandoned
- 2005-09-08 DK DK05807524T patent/DK1824515T3/da active
Also Published As
Publication number | Publication date |
---|---|
WO2006036484A3 (fr) | 2006-06-01 |
PL1824515T3 (pl) | 2009-08-31 |
US8084444B2 (en) | 2011-12-27 |
DE602005013690D1 (de) | 2009-05-14 |
EP1824515B1 (fr) | 2009-04-01 |
ES2321857T3 (es) | 2009-06-12 |
US20060069071A1 (en) | 2006-03-30 |
WO2006036484A2 (fr) | 2006-04-06 |
ATE427122T1 (de) | 2009-04-15 |
EP1824515A2 (fr) | 2007-08-29 |
CA2581364A1 (fr) | 2006-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY161021A (en) | Controlled release corticosteroid and methods for the treatment of otic disorders | |
ATE404206T1 (de) | Orale suspension mit meloxicam | |
WO2013078422A3 (fr) | Préparations et thérapies de substitution pour hormonothérapie naturelle combinée | |
ATE448777T1 (de) | Mittel für die transdermale verabreichung von nikotin | |
WO2009072007A3 (fr) | Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées | |
MX2020013533A (es) | Formulaciones y terapias de reemplazo de combinacion de hormonas naturales. | |
EP1827332A4 (fr) | Dispositifs donneurs de monoxyde d'azote topiques et leurs methodes d'utilisation a des fins therapeutiques | |
ATE516797T1 (de) | Topische polyaphron-zusammensetzung mit vitamin d und kortikosteroid | |
DE602005016551D1 (de) | Stabilisierte supergesättigte feste lösungen von steroidalen arzneimitteln | |
WO2012100097A3 (fr) | Compositions topiques de minocycline et leurs procédés d'utilisation | |
IL184145A0 (en) | Transdermal, therapeutic system with activatable oversaturation and controlled permeation promotion | |
DE602004027120D1 (de) | Orale und/oder topische Zubereitungen | |
NO20081790L (no) | Topiske formuleringer | |
GB2445674B (en) | Compositions for the topical treatment of eczema, psoriasis and the like | |
NO20064053L (no) | Androgen reseptormodulatorer | |
DK1824515T3 (da) | Behandling af dermatitis med dehydroepiandrosteron-glukokortikoidkombinationer | |
WO2007137224A3 (fr) | Méthode de traitement | |
MX2007002917A (es) | Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma. | |
MX2010005119A (es) | Corticosteroides para tratar la diarrea inducida por la epotilona o los derivados de epotilona. | |
CY1112973T1 (el) | Περαιτερω κρυσταλλικες μορφες ροσταφουροξινης | |
DK1732921T3 (da) | Thiomidderivater som progesteronreceptormodulatorer | |
GB2411573B (en) | Undergarment with linking and bracing device | |
WO2005034858A8 (fr) | Compositions et methodes pour traiter une douleur musculaire ou une atrophie musculaire | |
DK1635843T3 (da) | Terapi, der omfatter dienogest for hormonerstatning og depression | |
任秀珍 et al. | A Study of Stereotypes in Intercultural Communication |